PaxMedica, Inc.(NASDAQ:PXMD) 
PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indi...
Website: https://www.paxmedica.com
Founded: 2018
IPO Price: $5.25 (Aug 26, 2022)
Full Time Employees: 2
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-07-22
P
O 0.26
H 0.26
L 0.22
C 0.24
V 3,748
10EMA 0.24
20EMA 0.24
60EMA 0.24
120EMA 0.24
250EMA 0.24